Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

NRG Oncology (1)

Intervention

bevacizumab (1)

carboplatin (1)

computed tomography (1)

paclitaxel (1)

therapeutic conventional surgery (1)

Study Documents

Intervention Type

biological (1)

drug (1)

procedure (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

ovarian clear cell adenocarcinofibroma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma

Active, not recruiting

Fallopian Tube Endometrioid Adenocarcinoma
+29 more

Bevacizumab
+4 more

Birmingham, Alabama
+572 more

Jan 28, 2023